Merck & Co., Inc. (MRK) — Stock Score Summary

Merck & Co., Inc. (MRK) has a MoatMap StockRank of 96/100 based on Quality (70/100), Value (42/100), and Momentum (76/100) factor scores. The current signal is STRONG BUY. Merck & Co. faces upcoming patent cliffs for Keytruda and lacks the high-velocity asymmetric macro tailwinds required for our concentrated book.

Merck & Co., Inc. is a leading global pharmaceutical company focused on the discovery, development, manufacturing, and marketing of innovative medicines, vaccines, and animal health products. With a robust R&D pipeline and blockbuster franchises like Keytruda in oncology, Merck maintains a formidable global market presence, addressing significant medical needs across various therapeutic areas.

Key Financial Metrics

Price$120.48
Market Cap$296.1B
P/E (TTM)33.88
P/E (Forward)12.57
Price/Book6.47
Return on Equity18.9%
Return on Invested Capital20.7%
Debt/Equity106.94
Gross Margin76.7%
Operating Margin38.6%
Revenue Growth4.9%
Dividend Yield2.8%
Free Cash Flow$14.0B

Merck & Co., Inc. operates in the Drug Manufacturers - General industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Merck & Co., Inc.’s (MRK) StockRank?
MoatMap’s StockRank for Merck & Co., Inc. (MRK) is 96/100, with a Strong Buy signal. It is a composite of Quality (70), Value (42), and Momentum (76) factor ranks across MoatMap’s 19,000+ stock universe.
Does Merck & Co., Inc. have an economic moat?
Merck & Co., Inc. (MRK) has a Quality factor score of 70/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Merck & Co., Inc. a buy, hold, or sell?
MoatMap’s current signal for Merck & Co., Inc. (MRK) is Strong Buy, based on a StockRank of 96/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Merck & Co., Inc. in?
Merck & Co., Inc. (MRK) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry (United States).
Browse all ranked stocksMRK deep dive reportAI ChampionsHow we score stocksSense-check another stock